Ultra-Early Phase pathologies of Alzheimer's disease and other neurodegenerative diseases.

about

Role of Tau Acetylation in Alzheimer's Disease and Chronic Traumatic Encephalopathy: The Way Forward for Successful Treatment.

P2860

Q47256420-12143D1F-05D1-483C-B670-49FE2623A53D

P2860

Ultra-Early Phase pathologies of Alzheimer's disease and other neurodegenerative diseases.

Item

http://www.wikidata.org/entity/Q38700619

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Ultra-Early Phase pathologies ...... er neurodegenerative diseases.

@en

type

Item

label

Ultra-Early Phase pathologies ...... er neurodegenerative diseases.

@en

prefLabel

Ultra-Early Phase pathologies ...... er neurodegenerative diseases.

@en

P1476

Ultra-Early Phase pathologies ...... er neurodegenerative diseases.

@en

P2093

Hitoshi Okazawa

http://www.w3.org/2001/XMLSchema#string

P2860

Polar amino acid-rich sequences bind to polyglutamine tracts

Endogenous HMGB1 regulates autophagy

PQBP1, a factor linked to intellectual disability, affects alternative splicing associated with neurite outgrowth

Novel truncating mutations in the polyglutamine tract binding protein 1 gene (PQBP1) cause Renpenning syndrome and X-linked mental retardation in another family with microcephaly

Live-cell imaging reveals divergent intracellular dynamics of polyglutamine disease proteins and supports a sequestration model of pathogenesis.

Golabi-Ito-Hall syndrome results from a missense mutation in the WW domain of the PQBP1 gene

Loss-of-function presenilin mutations in Alzheimer disease. Talking Point on the role of presenilin mutations in Alzheimer disease

HMGB1, a pathogenic molecule that induces neurite degeneration via TLR4-MARCKS, is a potential therapeutic target for Alzheimer's disease.

Mutations in the PQBP1 gene prevent its interaction with the spliceosomal protein U5-15 kD

Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo

P304

361-377

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.2183/PJAB.93.022

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28603208

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

neurodegeneration

P932

5709537

http://www.w3.org/2001/XMLSchema#string

Ultra-Early Phase pathologies of Alzheimer's disease and other neurodegenerative diseases.

about

P2860

P2860

Ultra-Early Phase pathologies of Alzheimer's disease and other neurodegenerative diseases.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932